Molecular platforms for targeted drug delivery.

Area of Science:

• Pharmaceutical Research
• Drug Delivery Systems
• Molecular Therapeutics

Background:

• The concept of targeted drug delivery, or the "magic bullet" model, has been a long-standing goal in pharmaceutical research.
• Significant advancements, including monoclonal antibodies (mAbs) and antibody-drug conjugates, have translated selective drug targeting into clinical practice.
• Understanding disease pathophysiology enables the design of sophisticated drug delivery platforms for precise molecular targeting.

Purpose of the Study:

• To review various molecular platforms for targeted drug delivery.
• To focus on platforms with demonstrated clinical success and potential for targeted therapies.
• To highlight advancements in delivering single or multiple drugs to specific sites of action.

Main Methods:

• Literature review of targeted drug delivery systems.
• Analysis of clinical success of various molecular platforms.
• Discussion of design rationale for effective delivery systems.

Main Results:

• Monoclonal antibodies and antibody-drug conjugates represent successful clinical applications of targeted delivery.
• Tailored drug delivery platforms are designed based on disease understanding.
• Advanced platforms can deliver multiple drug copies or combinations for enhanced efficacy.

Conclusions:

• Targeted drug delivery significantly improves therapeutic outcomes and patient safety.
• Molecular platforms offer new strategies for treating intractable diseases.
• Continued research in drug delivery systems holds promise for future medical advancements.